Identification of Nifurtimox and Chrysin as Anti-Influenza Virus Agents by Clinical Transcriptome Signature Reversion

Identification of Nifurtimox and Chrysin as Anti-Influenza Virus Agents by Clinical Transcriptome Signature Reversion

The rapid development in the field of transcriptomics provides remarkable biomedical insights for drug discovery. In this study, a transcriptome signature reversal approach was conducted to identify the agents against influenza A virus (IAV) infection through dissecting gene expression changes in re...

Full description

Bibliographic Details
Main Authors:	Yijing Xin, Shubing Chen, Ke Tang, You Wu, Ying Guo
Format:	Article
Language:	English
Published:	MDPI AG 2022-02-01
Series:	International Journal of Molecular Sciences
Subjects:	influenza A virus clinical transcriptome transcriptome signature reversion nifurtimox chrysin network-based topological separation calculation
Online Access:	https://www.mdpi.com/1422-0067/23/4/2372

Similar Items

Benznidazole biotransformation in rat heart microsomal fraction without observable ultrastructural alterations: comparison to Nifurtimox-induced cardiac effects
by: María Montalto de Mecca, et al.
Published: (2008-09-01)

Dipyridamole potentiated the trypanocidal effect of nifurtimox and improved the cardiac function in NMRI mice with acute chagasic myocarditis
by: Sonia Santeliz, et al.

Estudo comparativo controlado com emprego de benznidazole, nifurtimox e placebo, na forma crônica da doença de Chagas, em uma área de campo com transmissão interrompida. I. Avaliação preliminar
by: José Rodrigues Coura, et al.
Published: (1997-04-01)

Chagas disease treatment efficacy markers: experiences from a Phase III study with nifurtimox in children
by: Ulrike Grossmann, et al.
Published: (2023-09-01)

Terapêutica da fase crônica da infecção experimental pelo Trypanosoma cruzi com o Benzonidazol e o Nifurtimox
by: Sonia G. Andrade, et al.
Published: (1989-09-01)

Antiviral Activity of Chrysin against Influenza Virus Replication via Inhibition of Autophagy
by: Seong-Ryeol Kim, et al.
Published: (2021-07-01)

Solid Nanomedicines of Nifurtimox and Benznidazole for the Oral Treatment of Chagas Disease
by: Miriam Rolon, et al.
Published: (2022-08-01)

Validation of In Vitro Trained Transcriptomic Radiosensitivity Signatures in Clinical Cohorts
by: John D. O’Connor, et al.
Published: (2023-07-01)

Chrysin Induces Apoptosis and Autophagy in Human Melanoma Cells via the mTOR/S6K Pathway
by: Jae-Han Lee, et al.
Published: (2022-06-01)

Tratamento da fase crônica da doença de Chagas com nifurtimox associado a corticóide
by: Anis Rassi, et al.
Published: (2002-12-01)

Identification of unique transcriptomic signatures through integrated multispecies comparative analysis and WGCNA in bovine oocyte development
by: Fa-Li Zhang, et al.
Published: (2023-05-01)

In Vitro Benznidazole and Nifurtimox Susceptibility Profile of Trypanosoma cruzi Strains Belonging to Discrete Typing Units TcI, TcII, and TcV
by: Susana Revollo, et al.
Published: (2019-10-01)

Development of Chrysin Loaded Oil-in-Water Nanoemulsion for Improving Bioaccessibility
by: Pisamai Ting, et al.
Published: (2021-08-01)

Protective effects of chrysin in rats with ovarian torsion
by: Deniz DİRİK, et al.
Published: (2021-06-01)

Protective effect of chrysin against cisplatin induced pulmonary toxicity in wister rats
by: M. Oladipo, et al.
Published: (2023-07-01)

Comparative transcriptomic and metagenomic analyses of influenza virus-infected nasal epithelial cells from multiple individuals reveal specific nasal-initiated signatures
by: Tan, Kai Sen, et al.
Published: (2018)

Preparation and Recognition Properties of Molecularly Imprinted Nanofiber Membrane of Chrysin
by: Yaohui Wang, et al.
Published: (2022-06-01)

Untargeted Metabolomics Based Prediction of Therapeutic Potential for Apigenin and Chrysin
by: Cole Cochran, et al.
Published: (2023-02-01)

Influenza-Omics and the Host Response: Recent Advances and Future Prospects
by: Joshua D. Powell, et al.
Published: (2017-06-01)

Chrysin: Perspectives on Contemporary Status and Future Possibilities as Pro-Health Agent
by: Monika Stompor-Gorący, et al.
Published: (2021-06-01)

Polyphenol chrysin for management of skin disorders: Current status and future opportunities
by: Mohammed Monirul Islam, et al.
Published: (2022-07-01)

Chrysin a promising anticancer agent: recent perspectives
by: Muhammad Shahbaz, et al.
Published: (2023-09-01)

Chrysin Protects against Memory and Hippocampal Neurogenesis Depletion in D-Galactose-Induced Aging in Rats
by: Ram Prajit, et al.
Published: (2020-04-01)

Spatial Transcriptomics Identifies Expression Signatures Specific to Lacrimal Gland Adenoid Cystic Carcinoma Cells
by: Acadia H. M. Moeyersoms, et al.
Published: (2023-06-01)

Virus-specific and shared gene expression signatures in immune cells after vaccination in response to influenza and vaccinia stimulation
by: Huy Quang Quach, et al.
Published: (2023-08-01)

Broad-Spectrum Preclinical Antitumor Activity of Chrysin: Current Trends and Future Perspectives
by: Ebrahim Rahmani Moghadam, et al.
Published: (2020-09-01)

Exploratory studies on chrysin via antioxidant, antimicrobial, ADMET, PASS and molecular docking evaluations
by: Adedotun F. Adesina, et al.
Published: (2024-06-01)

Chrysin-Induced G Protein-Coupled Estrogen Receptor Activation Suppresses Pancreatic Cancer
by: Hyun Kyung Lim, et al.
Published: (2022-08-01)

Preliminary trials of the gold nanoparticles conjugated chrysin: An assessment of anti-oxidant, anti-microbial, and in vitro cytotoxic activities of a nanoformulated flavonoid
by: Jasim Ahmed J., et al.
Published: (2022-08-01)

Padrão isoenzimático da cepa Y do Trypanosoma cruzi após quimioterapia específica Isoenzymatic pattern of Trypanosoma cruzi Y strain following specific chemoterapy
by: Rosângela Castro Silva, et al.
Published: (1989-03-01)

The role of chrysin against harmful effects of formaldehyde exposure on the morphology of rat fetus liver and kidney development
by: Songul Cuglan, et al.
Published: (2017-03-01)

Therapeutic potential of chrysin nanoparticle-mediation inhibition of succinate dehydrogenase and ubiquinone oxidoreductase in pancreatic and lung adenocarcinoma
by: Eman M. Ragab, et al.
Published: (2022-09-01)

Gene expression signature of human neuropathic pain identified through transcriptome analysis
by: Ling Hu, et al.
Published: (2023-02-01)

A Comprehensive RNA Expression Signature for Cervical Squamous Cell Carcinoma Prognosis
by: Jie Xiong, et al.
Published: (2019-01-01)

Pharmacological, Neurochemical, and Behavioral Mechanisms Underlying the Anxiolytic- and Antidepressant-like Effects of Flavonoid Chrysin
by: Juan Francisco Rodríguez-Landa, et al.
Published: (2022-05-01)

Chrysin alleviated CUMS-induced depressive-like behaviors in mice via directly targeting Fyn
by: Zhipeng Li, et al.
Published: (2023-07-01)

Evaluation of vasodilatory effect and antihypertensive effect of chrysin through in vitro and sub-chronic in vivo study
by: Wan Yin Tew, et al.
Published: (2023-01-01)

Identification of a Minimal 3-Transcript Signature to Differentiate Viral from Bacterial Infection from Best Genome-Wide Host RNA Biomarkers: A Multi-Cohort Analysis
by: Alberto Gómez-Carballa, et al.
Published: (2021-03-01)

Potential antiviral activities of chrysin against hepatitis B virus
by: Sajad Ahmad Bhat, et al.
Published: (2023-03-01)

Study of the Preparation and Properties of Chrysin Binary Functional Monomer Molecularly Imprinted Polymers
by: Long Li, et al.
Published: (2022-07-01)